Gastrointestinal stroma tumors (GIST): What is new in 2009?;Tumeurs stromales gastrointestinales (GIST) : quoi de neuf en 2009 ?

Annales de Pathologie

Volumn 29, Issue 1, 2009, Pages 20-23

  Emile, Jean François ^a,b   Scoazec, Jean Yves ^c   Coindre, Jean Michel ^d  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d INSTITUT BERGONIÉ   (France)

Author keywords

Gastric tumors; GIST; Immunohistochemistry; Intestinal tumors; KIT; Molecular pathology; PDGRA

Indexed keywords

IMATINIB; MEMBRANE PROTEIN; PROTEIN DOG 1; PROTEIN KINASE C THETA; UNCLASSIFIED DRUG; STEM CELL FACTOR RECEPTOR;

GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PROGNOSIS; PROTEIN ANALYSIS; SHORT SURVEY; TUMOR GROWTH; ARTICLE; DIFFERENTIAL DIAGNOSIS; FRANCE; GENETICS; INCIDENCE; PATHOLOGY;

DIAGNOSIS, DIFFERENTIAL; FRANCE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INCIDENCE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 60549090866     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annpat.2008.12.003     Document Type: Short Survey

References (15)

1. Hirota S., Isozaki K., Moriyama Y., Hashimoto K., Nishida T., Ishiguro S., et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279 (1998) 577-580
2. Joensuu H., Roberts P.J., Sarlomo-Rikala M., Andersson L.C., Tervahartiala P., Tuveson D., et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344 (2001) 1052-1056
3. Coindre J.M., Emile J.F., Monges G., Ranchère-Vince D., and Scoazec J.Y. Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy. Ann Pathol 25 (2005) 358-385
4. West R.B., Corless C.L., Chen X., Rubin B.P., Subramanian S., Montgomery K., et al. The novel marker, DOG-1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 165 (2004) 107-113
5. Dei Tos A.P., Rossi S., Flanagan A., Hogendoorn P.C., and Novelli M. The diagnostic utility of DOG-1 expression in KIT-negative GIST. J Clin Oncol 26 (2008) (suppl.; abstr 10551)
6. Fletcher C.D., Berman J.J., Corless C., Gorstein F., Lasota J., Longley B.J., et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 33 (2002) 459-465
7. Miettinen M., and Lasota J. Gastrointestinal stromal tumors: Pathology and prognosis at different sites. Semin Diagn Pathol 23 (2006) 70-83
8. Miettinen M., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 29 (2005) 52-68
9. Yamaguchi U., Nakayama R., Honda K., Ichikawa H., Hasegawa T., Shitashige M., et al. Distinct gene expression-defined classes of gastrointestinal stromal tumor. J Clin Oncol 26 (2008) 4100-4108
10. Agaimy A., Wünsch P.H., Hofstaedter F., Blaszyk H., Rümmele P., Gaumann A., et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 31 (2007) 113-120
11. Rubin B.P., Heinrich M.C., and Corless C.L. Gastrointestinal stromal tumour. Lancet 369 (2007) 1731-1741
12. Pasini B., McWhinney S.R., Bei T., Matyakhina L., Stergiopoulos S., Muchow M., et al. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 16 (2008) 79-88
13. Tarn C., Rink L., Merkel E., Flieder D., Pathak H., Koumbi D., et al. Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors. Proc Natl Acad Sci USA 105 (2008) 8387-8392
14. Corless C.L., and Heinrich M.C. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol Mech Dis 3 (2008) 557-586
15. Casali P.G., Jost L., Reichardt P., Schlemmer M., Blay J.Y., and ESMO Guidelines Working Group. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 Suppl. 2 (2008) ii35-ii38